Ertapenem Sodium
9 NDCs across 7 manufacturers|8 Generic,1 Brand
Ertapenem Sodium is used to treat abdominal abscess, bacteroides infections, escherichia coli infections, haemophilus infections, intraabdominal infections and klebsiella infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 21, 2001, and the first generic was approved Apr 16, 2018. In 2024, Medicare Part D spent $73 million on Ertapenem Sodium across 173,000 claims for 68,000 beneficiaries.
Ertapenem Sodium is available as 9 NDCs from 7 manufacturers (8 generic, 1 brand), with NADAC prices from $26.63 to $122.42 per EA — the most expensive product costs about 4.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
8G / 1B
Manufacturers
7
competing in market
Price Spread
$26.63 – $122.42
per EA
7d Activity
avg -4.5% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Fosun Pharma USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Penem Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
7 manufacturers producing ERTAPENEM SODIUM(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
INVANZ 1 GM VIAL | $122.4195 per EA | — |
ERTAPENEM 1 GRAM VIAL | $47.2056 per EA | -7.80% |
ERTAPENEM 1 GRAM VIAL | $26.6295 per EA | -4.06% |
ERTAPENEM 1 GRAM VIAL | $26.6295 per EA | -4.06% |
ERTAPENEM 1 GRAM VIAL | $26.6295 per EA | -4.06% |
ERTAPENEM 1 GRAM VIAL | $26.6295 per EA | -4.06% |
ERTAPENEM 1 GRAM VIAL | $26.6295 per EA | -4.06% |
ERTAPENEM 1 GRAM VIAL | $26.6295 per EA | -4.06% |
ERTAPENEM 1 GRAM VIAL | $26.6295 per EA | -4.06% |
Frequently Asked Questions
What is Ertapenem Sodium used to treat?
Ertapenem Sodium is used to treat abdominal abscess, bacteroides infections, escherichia coli infections, haemophilus infections, intraabdominal infections and klebsiella infections, per the National Library of Medicine's MED-RT classification.
When did Ertapenem Sodium become available as a generic?
FDA approved the first generic Ertapenem Sodium (ANDA) on Apr 16, 2018.
How much does Medicare spend on Ertapenem Sodium?
In 2024, Medicare Part D spent $73 million on Ertapenem Sodium across 173,000 claims for 68,000 beneficiaries.
How many Ertapenem Sodium products are on the market?
The Ertapenem Sodium drug market contains 9 NDCs from 7 manufacturers — 8 generic and 1 brand product.
What is the price range for Ertapenem Sodium?
NADAC reference prices for Ertapenem Sodium range from $26.6295 to $122.4195 per EA — the most expensive product costs about 4.6× the cheapest.
Is generic Ertapenem Sodium cheaper than brand?
The average generic NADAC for Ertapenem Sodium is $29.2015 per EA, versus $122.4195 for brand-labeled products — brand versions average about 4.2× the generic price.
Which manufacturers make Ertapenem Sodium?
7 manufacturers list Ertapenem Sodium in NADAC. Ranked by number of NDCs, the largest are Fosun Pharma USA Inc. (2), Endo USA Inc. (2), Merck Sharp & Dohme LLC (1), Apotex Corp. (1), Hikma Pharmaceuticals USA Inc. (1).
How has the price of Ertapenem Sodium changed recently?
Over the past 7 days, 0 Ertapenem Sodium NDCs rose and 8 fell, with a market-wide average change of -4.5%.